Showing results (81-90 of 237) with videos related to
Sort By:
Pageof 24
European Journal of Immunology|January 1, 1986
Immune response to diphtheria toxin and to different CNBr fragments: evidence for different B and T cell reactivitiesF Triebel, B Autran, S De Roquefeuil, et al.Molecular Immunology|November 1, 1990
A human TCR-Ig chimeric protein used to generate a TCR alpha chain variable region-specific mAbG Bismuth, H Gouy, R A Mariuzza, et al.British Journal of Haematology|April 1, 1978
Chronic lymphatic leukaemia: cellular effects of glucocorticoids in vitroF Homo, D Duval, P Meyer, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1984
Differential inhibition of human antigen-specific T cell clone proliferative responses by distinct monoclonal anti-HLA-DR antibodiesF Triebel, V Missenard-Leblond, M C Couty, et al.Leukemia Research|January 1, 1990
B8.7 antigen expression on B-CLL cells and its relationship to the LMW-BCGF responsivenessS Karray, C Leprince, H Merle-Beral, et al.Journal of Medical Virology|January 1, 1997
Additional mutations detected in sequential HIV-1 isolates from ZDV-treated patientsM Magierowska-Jung, H Agut, C Katlama, et al.AIDS (London, England)|June 5, 1999
Depletion in blood CD11c-positive dendritic cells from HIV-infected patientsF Grassi, A Hosmalin, D McIlroy, et al.The Journal of Experimental Medicine|December 1, 1981
Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytesF Plata, A F Tilkin, J P Lévy, et al.European Journal of Immunology|November 1, 1976
Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cellsF Plata, V Jongeneel, J C Cerottini, et al.AIDS (London, England)|December 1, 1991
MS-8209, a new Amphotericin B derivative that inhibits HIV-1 replication in vitro and restores T-cell activation via the CD3/TcR in HIV-infected CD4+ cellsD Céfai, F Hadida, M Jung, et al.Pageof 24